Indian Pharma - Live Stock Quotes, Stock Price Update and Analysis from

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.

Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks


Login Failure
(Please do not use this option on a public machine)
  Sign Up | Forgot Password?  

Indian Pharma Stocks 

Here are the latest stock price details of India's top Indian Pharma stocks. For more detailed updates, read our Indian Pharma sector report and check the latest Indian Pharma sector results.

» Result Scoreboard | Best Performing Stocks | Refresh
AARTI DRUGS 527.50 1.09% 525.70 0.91%
 More Info 
AJANTA PHARMA 1,006.45 3.68% 1,010.00 3.70%
 More Info 
ALEMBIC PHARMA 526.00 2.38% 527.55 2.52%
 More Info 
BIOCON LTD 576.50 0.85% 579.30 1.26%
 More Info 
CADILA HEALTHCARE 342.85 -0.13% 343.10 -0.13%
 More Info 
CIPLA 609.15 -0.31% 607.60 -0.41%
 More Info 
DIVIS LABORATORIES 1,085.35 0.77% 1,086.45 0.77%
 More Info 
GLENMARK PHARMA 566.05 0.90% 565.45 0.67%
 More Info 
INDOCO REMEDIES 176.35 3.40% 176.00 3.35%
 More Info 
IPCA LABS 740.30 0.00% 740.85 -0.25%
 More Info 
J.B.CHEMICALS 264.60 -0.11% 265.25 0.09%
 More Info 
LUPIN LTD 800.00 0.60% 800.60 0.76%
 More Info 
NATCO PHARMA 772.00 1.40% 774.00 1.71%
 More Info 
NIFTY 50 Not Listed 11,017.25 0.55%
 More Info 
ORCHID PHARMA LTD 6.80 -1.02% 18.90 -2.83%
 More Info 
PANACEA BIOTECH 212.35 0.33% 212.40 0.12%
 More Info 
PIRAMAL ENTERPRISES 2,505.15 -0.62% 2,503.00 -0.88%
 More Info 
S&P BSE SENSEX 36,536.65 0.51% Not Listed
 More Info 
STRIDES SHASUN LTD 347.05 1.46% 346.80 1.34%
 More Info 
SUN PHARMA 553.05 1.46% 553.35 1.54%
 More Info 
TORRENT PHARMA 1,433.00 0.75% 1,431.10 0.52%
 More Info 
WOCKHARDT LTD. 570.05 0.48% 570.35 0.55%
 More Info 

BSE prices: July 20, 2018  12:25:00 PM    NSE prices: July 20, 2018  12:25:00 PM

Indian Pharma Stocks Update

The NIFTY PHARMA Index is currently trading at 8,827.4 (up 0.9%). The index is down 4.6% over the last 30 days. And over the last 1 year, it has lost 13.7%.

Within the Indian Pharma sector, the top gainers are AJANTA PHARMA (up 3.7%) and INDOCO REMEDIES (up 3.4%). On the other hand, ORCHID PHARMA LTD (down 1.0%) and PIRAMAL ENTERPRISES (down 0.6%) are among the top losers.

Meanwhile, the benchmark NIFTY 50 is at 11,017.3 (up 0.6%).

Today's Market

Sensex Opens Marginally Higher; Infosys & ICICI Bank Top Gainers(09:30 am)

Asian stock markets are lower today as Japanese and Hong Kong shares fall. The Nikkei 225 is off 0.5% while the Hang Seng is also down 0.5%.

Related Views on News

LUPIN LTD Announces Quarterly Results (4QFY18); Net Profit Down 305.5%

Jul 19, 2018 | Updated on Jul 19, 2018

For the quarter ended March 2018, LUPIN LTD has posted a net profit of Rs 8 bn (down 305.5% YoY). Sales on the other hand came in at Rs 40 bn (down 5.2% YoY). Read on for a complete analysis of LUPIN LTD's quarterly results.

PANACEA BIOTECH Announces Quarterly Results (4QFY18); Net Profit Down 66.5%

Jun 20, 2018 | Updated on Jun 20, 2018

For the quarter ended March 2018, PANACEA BIOTECH has posted a net profit of Rs 86 m (down 66.5% YoY). Sales on the other hand came in at Rs 2 bn (up 0.3% YoY). Read on for a complete analysis of PANACEA BIOTECH's quarterly results.

INDOCO REMEDIES Announces Quarterly Results (4QFY18); Net Profit Up 14.3%

Jun 19, 2018 | Updated on Jun 19, 2018

For the quarter ended March 2018, INDOCO REMEDIES has posted a net profit of Rs 205 m (up 14.3% YoY). Sales on the other hand came in at Rs 3 bn (down 2.6% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

More Views on News

Most Popular

How to Avoid a 90% Loss Suffered by This Super Investor(The 5 Minute Wrapup)

Jul 12, 2018

Blindly following super investors is a dangerous game to play. Here's how you can avoid such mistakes.

The Answer to Your Wealth Worries: Small Caps (Especially Now)(Profit Hunter)

Jul 10, 2018

If you're worried about the markets - you are on the wrong track. This is opportunity - put your wealth-building hat on, instead - Richa shows you how...

The Multiple Problems with the Minimum Support Price (MSP) System(Vivek Kaul's Diary)

Jul 11, 2018

The price signals that MSP sends out, creates its own set of problems.

ICICI Pru Mutual Fund Tarakki Karega! - The Unethical Way?(Outside View)

Jul 11, 2018

PersonalFN explains how ICICI Prudential Mutual Fund flouted the norms of related party transactions while subscribing to the IPO of ICICI Securities.

PPF v/s Mutual Funds: Which Is Better?(Outside View)

Jul 10, 2018

PersonalFN highlights the key points of distinction between PPF and mutual funds.


Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms


Jul 20, 2018 12:25 PM